Merck to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Merck to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)

Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance

February 5, 2020 6:49 AM EST

Merck (NYSE: MRK) reported Q4 EPS of $1.16, $0.01 better than the analyst estimate of $1.15. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.98 billion.

GUIDANCE:

Merck sees FY2020 EPS of $5.62-$5.77, versus the consensus of $5.61. Merck sees... More